Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases

Podobne zapisy

• Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease
  od: Lin, Ying-Chuan, i wsp.
  Wydane: (2000)
• Molecular Basis for the Relative Substrate Specificity of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Proteases
  od: Beck, Zachary Q., i wsp.
  Wydane: (2001)
• Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease
  od: Lin, Ying-Chuan, i wsp.
  Wydane: (2010)
• Selection of Drug-Resistant Feline Immunodeficiency Virus (FIV) Encoding FIV/HIV Chimeric Protease in the Presence of HIV-Specific Protease Inhibitors
  od: Lin, Ying-Chuan, i wsp.
  Wydane: (2013)
• Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3
  od: Huitron-Resendiz, Salvador, i wsp.
  Wydane: (2004)